QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online June 25, 2007
doi: 10.1242/10.1242/dev.02865

This Article Figures Only Full Text Full Text (PDF) Supplementary Material Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jacobs, F. M. J. Articles by Smidt, M. P. Search for Related Content PubMed PubMed Citation Articles by Jacobs, F. M. J. Articles by Smidt, M. P. Social Bookmarking                         What's this?

Retinoic acid counteracts developmental defects in the substantia nigra caused by Pitx3 deficiency

Frank M. J. Jacobs^*, Simone M. Smits^*, Cornelle W. Noorlander, Lars von Oerthel, Annemarie J. A. van der Linden, J. Peter H. Burbach and Marten P. Smidt

Rudolf Magnus Institute of Neuroscience, Department of Pharmacology and Anatomy, University Medical Center Utrecht, Universiteitsweg 100, 3584 CG Utrecht, The Netherlands.

Author for correspondence (e-mail: m.p.smidt-2{at}umcutrecht.nl)

Accepted 3 May 2007

Selective neuronal loss in the substantia nigra (SNc), as described for Parkinson's disease (PD) in humans and for Pitx3 deficiency in mice, highlights the existence of neuronal subpopulations. As yet unknown subset-specific gene cascades might underlie the observed differences in neuronal vulnerability. We identified a developmental cascade in mice in which Ahd2 (Aldh1a1) is under the transcriptional control of Pitx3. Interestingly, Ahd2 distribution is restricted to a subpopulation of the meso-diencephalic dopaminergic (mdDA) neurons that is affected by Pitx3 deficiency. Ahd2 is involved in the synthesis of retinoic acid (RA), which has a crucial role in neuronal patterning, differentiation and survival in the brain. Most intriguingly, restoring RA signaling in the embryonic mdDA area counteracts the developmental defects caused by Pitx3 deficiency. The number of tyrosine hydroxylase-positive (TH+) neurons was significantly increased after RA treatment in the rostral mdDA region of Pitx3^-/- embryos. This effect was specific for the rostral part of the developing mdDA area, and was observed exclusively in Pitx3^-/- embryos. The effect of RA treatment during the critical phase was preserved until later in development, and our data suggest that RA is required for the establishment of proper mdDA neuronal identity. This positions Pitx3 centrally in a mdDA developmental cascade linked to RA signaling. Here, we propose a novel mechanism in which RA is involved in mdDA neuronal development and maintenance, providing new insights into subset-specific vulnerability in PD.

Key words: Pitx3, Retinoic acid, Aldehyde dehydrogenase, Development, Midbrain, Dopamine, Parkinson's disease, Ahd2, aldh1a1, Mouse

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				F. M. J. Jacobs, A. J. A. van der Linden, Y. Wang, L. von Oerthel, H. S. Sul, J. P. H. Burbach, and M. P. Smidt Identification of Dlk1, Ptpru and Klhl1 as novel Nurr1 target genes in meso-diencephalic dopamine neurons Development, July 15, 2009; 136(14): 2363 - 2373. [Abstract] [Full Text] [PDF]

				F. M. J. Jacobs, S. van Erp, A. J. A. van der Linden, L. von Oerthel, J. P. H. Burbach, and M. P. Smidt Pitx3 potentiates Nurr1 in dopamine neuron terminal differentiation through release of SMRT-mediated repression Development, February 15, 2009; 136(4): 531 - 540. [Abstract] [Full Text] [PDF]